Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-30

FDA Approved: FEBUXOSTAT — Original Application (Tris Pharma Inc)

View source ↗

Summary

The FDA approved an original application for febuxostat from Tris Pharma Inc, representing a generic product. The approval covers febuxostat for the treatment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)